Unlisted
| Company Name | 주식회사 셀레믹스 |
| English Name | Celemics, Inc. |
| Business Reg. No. | 1198635850 |
| CEO | 김효기, 이용훈 |
| Address | 서울특별시 금천구 가산디지털1로 131, A동 19층 및 20층 2004호 외 |
| Industry | 그 외 기타 의료용품 및 의약 관련제품 제조업 |
| Industry Code | 211 |
| Established | 20101129 |
| Phone | 02-6746-8067 |
| Website | www.celemics.com/ |
| Regular Employees | 41persons |
| Corp. Reg. No. | 1101114481282 |
Venture Certified
| 기술평가보증기업(기금) | 2013-03-29 ~ 2015-03-28 | 20130102369 | 2013-03-29 |
| 연구개발유형 | 2015-05-28 ~ 2017-05-27 | 20150104962 | 2013-03-29 |
| 기술평가보증기업(기금) | 2017-05-28 ~ 2019-05-27 | 20170108370 | 2013-03-29 |
| 기술평가보증기업(기금) | 2019-05-28 ~ 2021-05-27 | 20190107180 | 2013-03-29 |
| 혁신성장유형 | 2021-05-28 ~ 2024-05-27 | 20210707030231 | 2013-03-29 |
| 혁신성장유형 | 2024-05-28 ~ 2027-05-27 | 20240703030068 | 2013-03-29 |
Revenue CAGR -6.0%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 67B | 66B | 87B | 81B |
| Operating Profit | -19B | -58B | -57B | -60B |
| Net Profit | 123B | -39B | -48B | -52B |
| Total Assets | 294B | 181B | 222B | 269B |
| Total Liabilities | 22B | 22B | 36B | 35B |
| Total Equity | 272B | 159B | 186B | 234B |
Operating Loss: Op. profit -19B
▼ 13.8%
▲ 67.3%
▲ 62.6%
▼ 49.3%
▲ 286.4%
| Name | Position | Role |
|---|---|---|
| 이용훈 | 사내이사 | 경영총괄 |
| 김효기 | 사내이사 | 영업 및 마케팅 총괄 |
| 이상석 | 사내이사 | 경영지원총괄 |
| 백승권 | 사외이사 | 사외이사 |
| 김인영 | 감사 | 감사 |
| NPS Subscribers | 41persons |
| CEO | 김효기, 이용훈 |
| Est. Avg. Annual Salary | 5,36110K (44710K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 2012-09-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울특별시 금천구",
"ceo_name": "김효기, 이용훈",
"certificate": [
{
"cert_number": "20130102369",
"changes": "",
"disclosure_date": "2013-03-29",
"first_cert_date": "2013-03-29",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2013-03-29 ~ 2015-03-28"
},
{
"cert_number": "20150104962",
"changes": "",
"disclosure_date": "2015-05-28",
"first_cert_date": "2013-03-29",
"no": "2",
"type": "연구개발유형",
"valid_period": "2015-05-28 ~ 2017-05-27"
},
{
"cert_number": "20170108370",
"changes": "",
"disclosure_date": "2017-07-12",
"first_cert_date": "2013-03-29",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2017-05-28 ~ 2019-05-27"
},
{
"cert_number": "20190107180",
"changes": "",
"disclosure_date": "2019-06-26",
"first_cert_date": "2013-03-29",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2019-05-28 ~ 2021-05-27"
},
{
"cert_number": "20210707030231",
"changes": "",
"disclosure_date": "2021-07-07",
"first_cert_date": "2013-03-29",
"no": "5",
"type": "혁신성장유형",
"valid_period": "2021-05-28 ~ 2024-05-27"
},
{
"cert_number": "20240703030068",
"changes": "",
"disclosure_date": "2024-07-03",
"first_cert_date": "2013-03-29",
"no": "6",
"type": "혁신성장유형",
"valid_period": "2024-05-28 ~ 2027-05-27"
}
],
"company_name": "주식회사 셀레믹스",
"financials": {
"2022": {
"capital_stock": 4082074000,
"cost_of_sales": 6305447000,
"current_assets": 15612826000,
"current_liabilities": 2644840000,
"gross_profit": 2423493000,
"net_income": -4796931000,
"net_income_bs": -4796932000,
"non_current_assets": 6598603000,
"non_current_liabilities": 977353000,
"non_operating_expenses": 78383000,
"non_operating_income": 1015354000,
"operating_profit": -5733902000,
"revenue": 8728940000,
"sga_expenses": 8157395000,
"total_assets": 22211429000,
"total_equity": 18589235000,
"total_liabilities": 3622193000
},
"2023": {
"capital_stock": 4082074000,
"cost_of_sales": 5055097000,
"current_assets": 12685916000,
"current_liabilities": 1649083000,
"gross_profit": 1522481000,
"net_income": -3874540000,
"net_income_bs": -3874540000,
"non_current_assets": 5433907000,
"non_current_liabilities": 587139000,
"non_operating_expenses": 80055000,
"non_operating_income": 1974786000,
"operating_profit": -5769271000,
"revenue": 6577578000,
"sga_expenses": 7291752000,
"total_assets": 18119822000,
"total_equity": 15883600000,
"total_liabilities": 2236222000
}
},
"industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
"investment": [],
"phone": "02-6746-****",
"source": "pg_migration"
}{
"address": "서울특별시 금천구 가산디지털1로",
"brno": "119863****",
"cappedWarning": false,
"companyName": "주식회사셀레믹스",
"estimatedAvgAnnualSalary": 53608176,
"estimatedAvgMonthlySalary": 4467348,
"fetchedAt": "2026-03-05T11:26:24.485Z",
"industryCode": "242309",
"industryName": "의료용품 및 기타 의약 관련제품 제조업",
"joinDate": "20120901",
"last12MonthsHired": 0,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 17400320,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6731329",
"status": "1",
"styleCode": "1",
"subscriberCount": 41,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |